Patents by Inventor Carl Martin Tammemagi

Carl Martin Tammemagi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND PROGNOSIS OF LUNG CANCER
    Publication number: 20160060329
    Abstract: The present invention relates to methods and compositions for the detection of lung cancer. More particularly, the present invention provides monoclonal antibodies for the detection of lung cancer.
    Type: Application
    Filed: July 28, 2015
    Publication date: March 3, 2016
    Inventors: Donald SIN, Ayumu TAGUCHI, Stephen LAM, Samir HANASH, Xiaobo DUAN, Carl Martin TAMMEMAGI, Heidi Jo AUMAN, Frederica PERERA, Brad NELSON
  • Methods for detecting lung cancer and monitoring treatment response
    Patent number: 8728823
    Abstract: A method is described for detecting lung cancer comprising detecting an elevated level of a CTAP III-related biomarker in a biological sample from a subject at risk for developing lung cancer. Further, a method is described for predicting risk of developing lung cancer in a subject comprising detecting an elevated level of a CTAP III-related biomarker in a biological sample from a subject. Additionally, a method of monitoring the success of lung cancer treatment is described comprising detecting levels of a CTAP III-related biomarker in a biological sample from a subject undergoing treatment for lung cancer for comparison with a previous level obtained from the subject. Multivariate analysis may be incorporated into these methods, evaluating such clinical, or demographic risk factors as age, sex, smoking history, smoking status, smoking family history, education level, COPD, socio-economic status, body mass index and lung function. Kits for conducting such methods are described.
    Type: Grant
    Filed: November 24, 2008
    Date of Patent: May 20, 2014
    Assignee: British Columbia Cancer Agency Branch
    Inventors: Stephen Lam, John Yee, Michael Kuzyk, Don Sin, Marianne Dorthy Sadar, Carl Martin Tammemagi
  • METHODS FOR DETECTING LUNG CANCER AND MONITORING TREATMENT RESPONSE
    Publication number: 20100248290
    Abstract: A method is described for detecting lung cancer comprising detecting an elevated level of a CTAP III-related biomarker in a biological sample from a subject at risk for developing lung cancer. Further, a method is described for predicting risk of developing lung cancer in a subject comprising detecting an elevated level of a CTAP III-related biomarker in a biological sample from a subject. Additionally, a method of monitoring the success of lung cancer treatment with curative intent is described comprising detecting levels of a CTAP III-related biomarker in a biological sample from a subject undergoing treatment for lung cancer for comparison with the a previous level obtained from the subject. Multivariate analysis may be incorporated into these methods, evaluating such clinical, or demographic risk factors as age, sex, smoking history, smoking status, smoking family history, education level, COPD, socio-economic status, body mass index and lung function. Kits for conducting such methods are described.
    Type: Application
    Filed: November 24, 2008
    Publication date: September 30, 2010
    Applicant: BRITISH COLUMBIA CANCER AGENCY BRANCH
    Inventors: Stephen Lam, John Yee, Michael Kuzyk, Don Sin, Marianne Dorthy Sadar, Carl Martin Tammemagi